Skip to main content

Novo Nordisk A/S ADR (NY: NVO )

110.81 +2.00 (+1.83%)
Streaming Delayed Price Updated: 2:34 PM EST, Dec 6, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
April 24, 2017
Form 6-K
Source: SEC/Edgar
April 23, 2017
Form 6-K
Source: SEC/Edgar
April 09, 2017
Form 6-K
Source: SEC/Edgar
April 03, 2017
Form 6-K
Source: SEC/Edgar
April 03, 2017
Form 6-K
Source: SEC/Edgar
April 02, 2017
Form 6-K
Source: SEC/Edgar
April 02, 2017
Form 6-K
Source: SEC/Edgar
March 29, 2017
Form 6-K
Source: SEC/Edgar
March 27, 2017
Form 6-K
Source: SEC/Edgar
March 23, 2017
Form 6-K
Source: SEC/Edgar
March 23, 2017
Form 6-K
Source: SEC/Edgar
March 23, 2017
Form 6-K
Source: SEC/Edgar
March 19, 2017
Form 6-K
Source: SEC/Edgar
March 12, 2017
Form 6-K
Source: SEC/Edgar
March 01, 2017
Form F-6 POS
Source: SEC/Edgar
March 01, 2017
Form 6-K
Source: SEC/Edgar
February 26, 2017
Form 6-K
Source: SEC/Edgar
February 26, 2017
Form 6-K
Source: SEC/Edgar
February 14, 2017
Form 6-K
Source: SEC/Edgar
February 14, 2017
Form 6-K
Source: SEC/Edgar
February 08, 2017
Form 20-F
Source: SEC/Edgar
February 08, 2017
Form IRANNOTICE
Source: SEC/Edgar
February 08, 2017
Form 6-K
Source: SEC/Edgar
February 07, 2017
Form 6-K
Source: SEC/Edgar
February 06, 2017
Form 6-K
Source: SEC/Edgar
February 02, 2017
Form 6-K
Source: SEC/Edgar
February 01, 2017
Form SC 13G/A
Source: SEC/Edgar
January 24, 2017
Form 6-K
Source: SEC/Edgar
January 22, 2017
Form 6-K
Source: SEC/Edgar
January 16, 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.